Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma

SIMPLE SUMMARY: Antiplatelet therapy shows antitumor effect in several types of cancers. In liver disease, antiplatelet therapy reduces liver fibrosis and occurrence of HCC. However, the effect after diagnosis of hepatocellular carcinoma is still unknown. Therefore, we aimed to clarify the effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Tsuguru, Shibata, Michihiko, Oe, Shinji, Miyagawa, Koichiro, Honma, Yuichi, Harada, Masaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693153/
https://www.ncbi.nlm.nih.gov/pubmed/33142758
http://dx.doi.org/10.3390/cancers12113215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693153/
https://www.ncbi.nlm.nih.gov/pubmed/33142758
http://dx.doi.org/10.3390/cancers12113215

Ejemplares similares